[Surgical correction of symptomatic ventricular septal defects in patients less than 6 months of age]

A Cabrera Duro1, P Martínez Corrales, A Llorente Urcullo

  • 1Hospital Infantil de Cruces, Vizcaya.

Insights

Single surgery effectively corrects symptomatic ventricular septal defects in infants. This approach offers a safe and adequate solution for young children requiring intervention for VSDs.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Defects

Context:

  • Infants with symptomatic ventricular septal defects (VSDs) often require surgical intervention.
  • Early surgical management is crucial for improving outcomes in congenital heart disease.
  • Evaluating the efficacy of single-stage surgical repair is important for clinical practice.

Purpose:

  • To assess the effectiveness of a single surgical procedure for treating symptomatic interventricular septal defects in infants under six months old.
  • To determine the safety and feasibility of early surgical correction for VSDs.
  • To analyze the short-term outcomes and complications associated with VSD repair.

Summary:

  • Forty-two infants with symptomatic VSDs underwent surgical repair using deep hypothermia.
  • No perioperative mortality was observed, with short intensive care unit and hospitalization stays.
  • While some immediate complications occurred, only two patients required reintervention during follow-up.

Impact:

  • One-time surgery appears to be an adequate and safe method for correcting symptomatic VSDs in this age group.
  • The findings support the use of early, single-stage surgical intervention for VSDs.
  • This study contributes to the understanding of surgical outcomes for congenital heart defects in neonates and infants.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...